International Immunology, Vol. 14, No. 1, 13-22,
January 2002
© 2002 Japanese Society for Immunology
HIV-1 viral protein R compromises cellular immune function in vivo
Department of Pathology and Laboratory Medicine, University of Pennsylvania, 505 Stellar Chance Laboratories, 422 Curie Boulevard, Philadelphia, PA 19104, USA
1 Department of Infectious Diseases & Microbiology, University of Pittsburgh, PA 15261, USA
2 The Wistar Institute, 3601 Spruce Street, Philadelphia, PA 19104, USA
Correspondence to: D. B. Weiner
HIV-1 viral protein R (Vpr) is a virion-associated gene product that profoundly affects T cell proliferation, induces apoptosis and can affect cytokine production in part through interfering with NF-
B-mediated transcription from host cells. Collectively, these effects support that Vpr could influence immune activation in vivo. However, this effect of Vpr has not been explored previously. Here we examined the effect of Vpr expression in an in vivo model system on the induction of antigen-specific immune responses using a DNA vaccine model. Vpr co-vaccination significantly altered the immune response to co-delivered antigen. Specifically, in the presence of Vpr, inflammation was markedly reduced compared to antigen alone. Vpr reduced antigen-specific CD8-mediated cytotoxic T lymphocyte activity and suppressed Th1 immune responses in vivo as evidenced by lower levels of IFN-
. In the presence of Vpr, there is a profound shift in isotype towards a Th2 response as determined by the IgG2a:IgG1 ratio. The data support that Vpr compromises antigen-specific immune responses and ultimately effector cell function, thus confirming a strong selective advantage to the virus at the expense of the host.
Keywords: antigen-presenting cell, antigen-specific immune response, HIV-1 viral protein R, T cell activation, Th1/Th2 cytokine, vaccination
Transmitting editor: D. R. Green
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
B. Majumder, M. L. Janket, E. A. Schafer, K. Schaubert, X.-L. Huang, J. Kan-Mitchell, C. R. Rinaldo Jr., and V. Ayyavoo Human Immunodeficiency Virus Type 1 Vpr Impairs Dendritic Cell Maturation and T-Cell Activation: Implications for Viral Immune Escape J. Virol., July 1, 2005; 79(13): 7990 - 8003. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Muthumani, D. S. Hwang, A. Y. Choo, S. Mayilvahanan, N. S. Dayes, K. P. Thieu, and D. B. Weiner HIV-1 Vpr inhibits the maturation and activation of macrophages and dendritic cells in vitro Int. Immunol., February 1, 2005; 17(2): 103 - 116. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P. Ramanathan, E. Curley III, M. Su, J. A. Chambers, and D. B. Weiner Carboxyl Terminus of hVIP/mov34 Is Critical for HIV-1-Vpr Interaction and Glucocorticoid-mediated Signaling J. Biol. Chem., November 27, 2002; 277(49): 47854 - 47860. [Abstract] [Full Text] [PDF] |
||||


